- Chart
- Trade
- Markets
- Cryptocurrencies
- Crypto Screener
- Prices
- DeFi Coins
- Market Cap charts
- DeFi Market Cap charts
- Bitcoin
- XRP
- Ethereum
- Bitcoin Cash
- EOS
- Stellar
- Litecoin
- Bitcoin SV
- Tether
Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
- Currencies
- Stocks
- Earnings Calendar
- Stock Screener
- Large-cap
- Top gainers
- Top losers
- Most active
- Most volatile
- Overbought
- Oversold
- All-time high
- All-time low
- High-dividend
- Sector & Industry
Apple, Advanced Micro Devices Inc, Amazon Com Inc, Tesla, Inc, Netflix, Inc, Facebook Inc
- Indices
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
- Futures
- Bonds
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
- Sparks
- Daily news
- Cryptocurrencies
- Screeners
- Community
Provectus Biopharmaceuticals, Inc
PVCT
OTC
Provectus Biopharmaceuticals, Inc
PVCT OTC
PVCT
Provectus Biopharmaceuticals, Inc OTC
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
PVCT Stock Chart
After selling was absorbed, PVCT moved into accumulation for much of December, and after the sleepy holiday last week, this stock is breaking out of accumulation on good volume. I'm long on it.
1
Valuation
Enterprise Value/EBITDA, TTM
—
Enterprise Value, FQ
—
Market Cap — Basic
—
Number of Employees
—
Number of Shareholders
—
Price/Earnings, TTM
—
Price/Revenue, TTM
—
Price/Book Ratio, FY
—
Price/Sales Ratio, FY
—
Balance Sheet
Current Ratio, FQ
—
Debt to Equity, FQ
—
Net Debt, FQ
—
Quick Ratio, FQ
—
Total Assets, FQ
—
Total Debt, FQ
—
Operating Metrics
Return on Assets, TTM
—
Return on Equity, TTM
—
Return on Invested Capital, TTM
—
Revenue per Employee, TTM
—
Price History
Average Volume (10 day)
—
Beta - 1 Year
—
Price - 52 Week High
—
Price - 52 Week Low
—
Dividends
Dividends Paid, FY
—
Dividends per Share, FY
—
Expected Annual Dividends
—
Dividends Yield
—
Margins
Net Margin, TTM
—
Gross Margin, TTM
—
Operating Margin, TTM
—
Pretax Margin, TTM
—
Income Statement
Basic EPS, Net Income
—
Earnings per Share, Basic, TTM
—
EBITDA, TTM
—
Gross Profit, FY
—
Last Annual EPS
—
Last Annual Revenue, FY
—
Net Income, FY
—
Total Revenue, FY
—
Free Cash Flow, TTM
—
Sector: Health Technology
Industry: Pharmaceuticals: Other
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company. It engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treats several life threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter in 2002 and is headquartered in Knoxville, TN.